Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Treatment with CTLA4-Ig inhibits rejection of liver allografts from FIt3-ligand-treated donors.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Treatment with CTLA4-Ig inhibits rejection of liver allografts from FIt3-ligand-treated donors.
Treatment with CTLA4-Ig inhibits rejection of liver allografts from FIt3-ligand-treated donors. Transplant Proc. 1999 Feb-Mar; 31(1-2):453.
View in:
PubMed
subject areas
Abatacept
Adjuvants, Immunologic
Animals
Antigens, CD
Antigens, Differentiation
CTLA-4 Antigen
Graft Rejection
Graft Survival
Immunoconjugates
Immunosuppressive Agents
Liver Transplantation
Membrane Proteins
Mice
Mice, Inbred C3H
Mice, Inbred Strains
Transplantation, Homologous
authors with profiles
John Fung